Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-53.03	180.39	384.05
Graham Fair Price	59.76	16229.86	10158.99
PEG	-76.23	0.32	-1.35
Price/Book	4.57	3.06	2.93
Price/Cash Flow	1.23	-342.97	-347.24
Prices/Earnings	-58.05	48.97	116.74
Price/Sales	-10.96	11.89	13.35
Price/FCF	1.23	-342.97	-347.24
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	5.38	0.40	0.38
Operating Margin	2603.70	0.04	< 0.005
ROA	144.85	0.01	< 0.005
ROE	< 0.005	0.02	149.28
ROIC	< 0.005	< 0.005	326.58
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.10	0.00	-100.00
Dividends QOQ	0.00	-1.00	-100.00
EBIT QOQ	-0.90	31.13	3345.69
EPS QOQ	-0.86	1.52	76.46
FCF QOQ	0.00	-0.07	-100.00
Revenue QOQ	0.02	0.19	1005.90
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	98.32	86.77	-11.75
Days Sales Outstanding (DSO)	113.51	106.99	-5.74
Inventory Turnover	0.92	1.04	13.31
Debt/Capitalization	0.11	0.11	2.57
Quick Ratio	1.53	1.57	2.50
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	27044.02	28223.66	4.36
Cash	3975.25	4115.08	3.52
Capex	-343.87	300.41	-12.64
Free Cash Flow	-228.08	-244.34	-7.13
Revenue	5932.48	7049.59	18.83
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	2.21	2.04	-8.03
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1.90	-0.50	-73.48
Naive Interpretation	Member

06 - Financial Health · Bad

Rating